arXiv paper· natural language processing (neurosymbolic AI for clinical decision support)· method paper

Accountable AI with Grounded, Faithful, Consistent, Actionable Rationales: A Case Study in Clinical Trial Matching with VERDICT

Zikai Zhou, Yufei Jin, Yilin Xu, Yu-Chiang Wang, Chieh-Ju Chao, Monica S. Lam

cs.CL · cs.CY · cs.LO

Quick verdict

VERDICT turns trial matching into SMT so decisions are verifiable and self-faithful; strong results, but LLM-derived labels and small audits temper claims.

Summary

The paper introduces VERDICT, an LLM-agent framework for accountable clinical trial eligibility matching. It decomposes the task: LLMs formalize trial criteria into SMT constraints and extract patient evidence, marking each condition observed, imputed, or unresolved under explicit policies; a Z3 SMT solver derives the eligibility decision and derivation trace; MaxSMT computes assumptions and minimal pivotal conditions; a final LLM verbalizes the rationale. The authors define self-faithfulness — flipping reported pivotal conditions should flip the decision — and prove VERDICT satisfies it by construction. On a 552-pair SIGIR-2016-derived benchmark (labels from a five-judge GPT-5 panel) and 363 TREC 2021 pairs, VERDICT achieves the strongest decision accuracy among evaluated LLM-only and neurosymbolic baselines; semantic-parsing errors affect only 2.8% of TREC decisions. In a 32-pair clinician review, VERDICT rationales win 90.6% (vs ZSPM) and 75.0% (vs LLMMATCH) tie-adjusted, and end-to-end pivotal flip rates reach 84.3% versus 26.6–65.0% for baselines. Main limitations: SIGIR gold labels are LLM-derived with clinician validation on only 32 pairs by co-author clinicians; the TREC subset retains only compilable trials; counterfactual evaluation is one-directional; records are synthetic.

Review complete

Assessment at a glance

natural language processing (neurosymbolic AI for clinical decision support)

5

risk flags identified

● high 0

● medium 3

● low 2

Reproducibility readinesshigh
Code & data availableyes
Review confidencemedium
AI text signal0/20 passages flagged
Deep research viableCode-reproducible

5 strengths · 5 weaknesses · 5 author questions

AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.

Levels reflect verification complexity — not a quality score. Evolve never rates your paper.

Key claims under review

  • LLM-based matchers apply missing-data policies inconsistently (71–81% adherence even under the most explicit per-condition setting, Table 5) and produce rationales causally unfaithful to their own decisions (flip rates 26.6–65.0%, Table 6).
  • VERDICT translates trial criteria, patient evidence, and policies into SMT, so the decision, trace, assumptions, and pivotal conditions are verifiably correct with respect to the formal representation, with self-faithfulness (PivotalFlipRate = 1) by construction (Theorem 2, Corollary 2).
  • VERDICT achieves the strongest decision accuracy among evaluated LLM-only and neurosymbolic baselines on both benchmarks, with semantic-parsing errors changing only 2.8% of TREC decisions (Appendix L).
  • Clinicians prefer VERDICT's rationales (90.6% vs ZSPM, 75.0% vs LLMMATCH tie-adjusted, Table 3) and its end-to-end pivotal flip rate of 84.3% far exceeds all baselines (Table 26).

Strengths

  • Formally grounded accountability framework

    Definitions 1–5 and Theorems 1–2 give a precise accountability contract: decisions, traces γ, assumptions ρ and pivotal conditions δ are derived from SMT/MaxSMT (§3.2), and self-faithfulness (PivotalFlipRate = 1) holds by construction w.r.t. the formal representation (Corollary 2), not merely by evaluation.

  • Unusually serious baseline engineering

    Appendix C documents a six-variant prompt search over three design axes, selecting the strongest LLMMATCH and CoT variants on a dev split; TrialGPT's aggregation rule and ZSPM's middle-bucket mapping are also dev-tuned (App. B), pre-empting the 'weak baseline' objection.

  • Transparent, reproducible evaluation

  • Quantified error provenance

  • Candid risk analysis

Weaknesses

  • LLM-derived gold labels with co-author clinician validation

  • TREC evaluation set filtered by VERDICT's own coverage

  • Empirical self-faithfulness falls well short of the by-construction 100%

  • ZSPM's counterfactual prompt differs from its accuracy prompt

  • By-construction metrics compared against by-observation baselines

Full Review Report

$1.99 · one-time

Unlock the complete preliminary analysis Evolve produced for this paper.

Report preview

Scope & Claims

The paper reframes clinical trial eligibility matching as an *accountable decision-making* problem with four requirements: verified rationales (grounding), explicit assumptions (faithfulness), policy consistency, and pivotal conditions (actionability). Its central conceptual move is *self-faithfulness* (Definitions 2–3, Theorem 1): if a decision-maker declares conditions pivotal, flipping them must flip the decision — an annotation-free accountability test operationalized as PivotalFlipRate. VERDICT (§3) realizes this by splitting the task into LLM semantic parsing (trial criteria → SMT formula ϕt; patient record → per-condition resolution ri with OBSERVED/IMPUTED/UNRESOLVED provenance under an explicit policy set Π) and solver decision-making (Z3 SMT → decision d and trace γ; MaxSMT → assumptions ρ and minimal pivotal conditions δ). The claims under test: (i) LLM matchers are policy-inconsistent and self-unfaithful; (ii) VERDICT matches or beats the strongest LLM-only and neurosymbolic baselines on accuracy; (iii) it attains perfect consistency and near-perfect end-to-end self-faithfulness; (iv) clinicians prefer its rationales.

The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.

  • All 5 strengths & 5 weaknesses, analyzed in detail
  • 5 risk flags with severity, section & reviewer questions
  • Methods & statistical evidence assessment
  • 5 questions a peer reviewer would ask
  • Full six-dimension evaluation report & recommendations

One-time purchase · this paper only

One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.

Frequently asked questions

What is VERDICT in clinical trial matching?

VERDICT is an LLM-based agent that converts a clinical trial's eligibility criteria, a patient record, and missing-data policies into SMT (Satisfiability Modulo Theories) formulas. A Z3 solver derives the eligibility decision and its derivation trace, and a MaxSMT solver derives the assumptions and the minimal conditions whose change would flip the decision — so identical cases are decided identically and every rationale is mechanically derived rather than freely generated.

What is self-faithfulness as defined in this paper?

An automatic accountability test: if a decision system names certain conditions as pivotal (the reasons for its decision), then changing those conditions must change the decision. The paper measures it via PivotalFlipRate; VERDICT achieves 100% on its formal representation by construction and about 84% end-to-end, while LLM-only baselines reach only 26.6–65.0%.

How accurate is VERDICT compared to other clinical trial matching systems?

The paper reports the strongest decision accuracy among evaluated LLM-only and neurosymbolic baselines on a 552-pair benchmark derived from SIGIR 2016 and 363 TREC 2021 pairs — for example, a clinician-adjusted lenient F1 of 0.902 at the GPT-4.1 backbone versus 0.886 for the strongest prompted baseline — with semantic-parsing errors affecting only 2.8% of TREC decisions.

What are the main limitations of the VERDICT paper?

Reference labels for the SIGIR benchmark come from an LLM judge panel with clinician validation on only 32 pairs by clinician co-authors; the TREC evaluation covers only trials whose criteria could be compiled into the formal representation; the counterfactual self-faithfulness test runs in one direction only (ineligible to eligible); and all patient records are synthetic rather than real electronic health records.

About this review

This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.

  • Table 2 (headline accuracy) and §5.1 fall inside a sampling gap in the provided excerpt; accuracy statements in this review rely on the abstract, Table 16 (clinician-adjusted) and the appendix tables.
  • Appendices A.1–A.3 (parser/value-miner implementation), part of Appendix D, the opening of §5.2, and the tail of Appendix N are within sampling gaps; those implementation and human-eval details are only partially seen.

Go deeper on this paper

Wrote a paper? Stress-test it before reviewers do.

Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.

Scan your paper
Accountable AI with Grounded, Faithful, Consistent, Actionable Rationales: A Case Study in Clinical Trial Matching with VERDICT | Evolve.Pub